American Heart Association Journals Circulation Representing the best in the field of cardiovascular medicine and science as well as basic science Editor-in-Chief: Joseph A Hill, MD, PhD View latest issue
Vol 151, No 2 | Circulation - AHA ASA Journals Recognized Outstanding Reviewers for Circulation in 2024 Darren K McGuire, James A de Lemos, Joseph A Hill, on behalf of the Circulation Editors Team PDF Full Text
| AHA ASA Journals Circulation publishes original research manuscripts, review articles, and other content related to cardiovascular health and disease, including observational studies, clinical trials, epidemiology, health services and outcomes studies, and advances in basic and translational research
American Heart Association Journals Arteriosclerosis, Thrombosis, and Vascular Biology Circulation Circulation Research Hypertension Stroke Journal of the American Heart Association Circulation: Arrhythmia and Electrophysiology Circulation: Cardiovascular Imaging Circulation: Cardiovascular Interventions Circulation: Population Health and Outcomes Circulation: Genomic and Precision Medicine Circulation: Heart Failure Stroke
American Heart Association Journals Circulation Circulation Research Hypertension Stroke Journal of the American Heart Association Circulation: Arrhythmia and Electrophysiology Circulation: Cardiovascular Imaging Circulation: Cardiovascular Interventions Circulation: Population Health and Outcomes Circulation: Genomic and Precision Medicine Circulation: Heart Failure
2026 AHA ACC ACCP ACEP CHEST SCAI SHM SIR SVM SVN Guideline for the . . . Category E1 is compatible with SCAI SHOCK stage C 3 Category E2 is defined by refractory cardiogenic shock (SCAI D-E) or cardiac arrest without restoration of spontaneous circulation after 30 minutes of resuscitation Respiratory failure in category E-R is defined by the need for noninvasive or invasive positive pressure ventilation
American Heart Association Journals Circulation Representing the best in the field of cardiovascular medicine and science as well as basic science Editor-in-Chief: Joseph A Hill, MD, PhD View latest issue
Reactivation of Oxidized Soluble Guanylate Cyclase as a Novel Treatment . . . Pharmacological treatments for fibrocalcific aortic valve stenosis (FCAVS) have been elusive for >50 years Here, we tested the hypothesis that reactivation of oxidized sGC (soluble guanylate cyclase), the primary receptor for nitric oxide, with ataciguat is a safe and efficacious strategy to slow progression of FCAVS